- 公司资讯
- 智通财经网 | 2024年01月03日 20:14Affimed(AFMD.US)以600万美元出售抗体技术研发部门子公司AbCheck
- finviz | 2022年09月12日 18:24Does Affimed (NASDAQ:AFMD) Have A Healthy Balance Sheet?
- finviz | 2022年09月05日 06:05Affimed To Provide a Clinical Update on AFM24 Monotherapy Dose-escalation at European Society for Medical Oncology (ESMO) Congress 2022
- finviz | 2022年09月01日 18:30Affimed to Present at Upcoming Investor Conferences
- finviz | 2022年08月24日 19:58Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks
- finviz | 2022年08月20日 20:48Calculating The Intrinsic Value Of Affimed N.V. (NASDAQ:AFMD)
- finviz | 2022年08月11日 19:45Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates
- finviz | 2022年08月11日 18:30Affimed Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Progress
- finviz | 2022年08月04日 18:30Affimed to Report Second Quarter 2022 Financial Results & Corporate Update on August 11, 2022
- finviz | 2022年07月25日 22:437 Undervalued Biotech Stocks to Buy Before They Boom
- finviz | 2022年07月13日 21:02Affimed (NASDAQ:AFMD) shareholders have endured a 57% loss from investing in the stock a year ago
- finviz | 2022年07月01日 04:00Affimed Establishes Scientific Advisory Board
- finviz | 2022年06月10日 22:31Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)
- finviz | 2022年06月01日 19:55Affimed N.V. (AFMD) Reports Q1 Loss, Misses Revenue Estimates
- finviz | 2022年06月01日 18:30Affimed Reports First Quarter 2022 Financial Results and Highlights Recent Operational Progress
- finviz | 2022年05月27日 05:05Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
首页
上页
下页